On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Takao Orii

ResearcherPublications, citations & collaboration network

Takao Orii is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Takao Orii have?

ScholarIQindexed works

Takao Orii has 78 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Takao Orii have?

ScholarIQcitation count

Takao Orii has 372 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Takao Orii?

ScholarIQh-index

Takao Orii has an h-index of 9 in OpenAlex.

What is the i10-index of Takao Orii?

ScholarIQi10-index

Takao Orii has an i10-index of 9 in OpenAlex.

What is the OpenAlex record for Takao Orii?

ScholarIQopenalex

The OpenAlex for Takao Orii is on the source record.

What are the most-cited papers on Takao Orii?

ScholarIQmost cited works
Establishment of the MID‐NET<sup>®</sup> medical information database network as a reliable and valuable database for drug safety assessments in Japan
Mitsune Yamaguchi, Satomi Inomata, Sayoko Harada, Yu Matsuzaki, Maiko Kawaguchi, Mayuko Ujibe, Mari Kishiba, Yoshiaki Fujimura, Michio Kimura, Koichiro Murata, Naoki Nakashima, Masaharu Nakayama, Kazuhiko Ohe, Takao Orii, Eizaburo Sueoka, T. Suzuki, Hideto Yokoi, Fumitaka Takahashi, Yoshiaki Uyama
Pharmacoepidemiology and Drug Safety. 201991 CitationsOPEN ACCESS
Eculizumab Dosing Intervals Longer than 17 Days May Be Associated with Greater Risk of Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria
Hirokazu Nakayama, Kensuke Usuki, Hirotoshi Echizen, Ryuichi Ogawa, Takao Orii
Biological and Pharmaceutical Bulletin. 201644 CitationsOPEN ACCESS
Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information
Chia‐Hsien Chang, Makiko Kusama, Shunsuke Ono, Yuichi Sugiyama, Takao Orii, Manabu Akazawa
BMJ Open. 201343 CitationsOPEN ACCESS
The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies
Kaori Yamada, Maori Itoh, Yoshiaki Fujimura, Michio Kimura, Koichiro Murata, Naoki Nakashima, Masaharu Nakayama, Kazuhiko Ohe, Takao Orii, Eizaburo Sueoka, T. Suzuki, Hideto Yokoi, Chieko Ishiguro, Yoshiaki Uyama, on behalf of MID‐NET project group
Pharmacoepidemiology and Drug Safety. 201940 Citations
Urinary Lipocalin-Type Prostaglandin D Synthase: A Potential Marker for Early Gentamicin-Induced Renal Damage?
Hirokazu Nakayama, Hirotoshi Echizen, Tomoko Gomi, Yuko Shibuya, Yoshitsugu Nakamura, Kiyoharu Nakano, Hiroyuki Arashi, Tsutomu Itai, Satoshi Ohnishi, Masayo Tanaka, Takao Orii
Therapeutic Drug Monitoring. 200918 Citations

Related on ScholarIQ

470M+ articles · 14-day free trial